Literature DB >> 29866925

Inhibition of Discoidin Domain Receptor 1 Prevents Stroma-Induced Peritoneal Metastasis in Gastric Carcinoma.

Hyejin Jin1, In-Hye Ham1,2, Hye Jeong Oh1, Cheong A Bae1,2, Dakeun Lee3, Young-Bae Kim3, Sang-Yong Son1, Yong-Joon Chwae4, Sang-Uk Han1, Rolf A Brekken5, Hoon Hur6,2.   

Abstract

Discoidin domain receptor 1 (DDR1) is activated by fibrillar (triple-helical) collagens and collagen IV, which are major components of tumor stroma; thus, DDR1 might be a critical mediator of communication between cancer cells and stroma. The aim of this study was to investigate the effect of DDR1 inhibition on stroma-induced peritoneal metastasis in gastric carcinoma. We analyzed by immunohistochemistry the correlation between DDR1 expression and the pattern of recurrence in gastric carcinoma tissues from a previously characterized and established gastric carcinoma patient cohort. We also cocultured human gastric carcinoma cell lines with gastric cancer-associated fibroblasts (CAF) and investigated DDR1 expression and activation. We evaluated CAF-induced tumorigenic properties of gastric carcinoma cell lines and the effect of a DDR1-specific inhibitor in organotypic cultures and in a peritoneal seeding xenograft animal model. The expression of DDR1 in gastric cancer tissues was positively associated with early recurrence (P = 0.043) and a high incidence of peritoneal recurrence (P = 0.036). We confirmed that coculturing with CAFs elevated DDR1 protein expression in gastric carcinoma cell lines and enhanced gastric carcinoma cell line spheroid formation in organotypic cultures in a tumor cell DDR1-dependent manner. Coimplantation of CAFs with gastric carcinoma cells enhanced peritoneal tumor formation in vivo, an effect that was sensitive to pharmacologic inhibition of DDR1.Implications: This study highlights that CAF-induced elevation of DDR1 expression in gastric carcinoma cells enhances peritoneal tumorigenesis, and that inhibition of DDR1 is an attractive strategy for the treatment of gastric carcinoma peritoneal metastasis. Mol Cancer Res; 16(10); 1590-600. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29866925     DOI: 10.1158/1541-7786.MCR-17-0710

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  18 in total

Review 1.  Complex roles of discoidin domain receptor tyrosine kinases in cancer.

Authors:  V Mehta; H Chander; A Munshi
Journal:  Clin Transl Oncol       Date:  2021-02-25       Impact factor: 3.405

2.  A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer.

Authors:  Soyeon Ko; Kyung Hee Jung; Young-Chan Yoon; Beom Seok Han; Min Seok Park; Yun Ji Lee; Sang Eun Kim; Ye Jin Cho; Pureunchowon Lee; Joo Han Lim; Ji-Kan Ryu; Kewon Kim; Tae Young Kim; Sungwoo Hong; So Ha Lee; Soon-Sun Hong
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

3.  CircRNA PVT1 modulated cell migration and invasion through Epithelial-Mesenchymal Transition (EMT) mediation in gastric cancer through miR-423-5p/Smad3 pathway.

Authors:  Huanqin Li; Shuai Xue; Xiaohong Zhang; Fan Li; Songhua Bei; Li Feng
Journal:  Regen Ther       Date:  2022-05-23       Impact factor: 3.651

4.  2-Amino-2,3-dihydro-1H-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer Efficacy.

Authors:  Dongsheng Zhu; Huocong Huang; Daniel M Pinkas; Jinfeng Luo; Debolina Ganguly; Alice E Fox; Emily Arner; Qiuping Xiang; Zheng-Chao Tu; Alex N Bullock; Rolf A Brekken; Ke Ding; Xiaoyun Lu
Journal:  J Med Chem       Date:  2019-08-02       Impact factor: 7.446

5.  Promotion of miR-221-5p on the Sensitivity of Gastric Cancer Cells to Cisplatin and Its Effects on Cell Proliferation and Apoptosis by Regulating DDR1.

Authors:  Xiaomeng Jiang; Menglin Jiang; Shuhua Guo; Pengpeng Cai; Wei Wang; Yi Li
Journal:  Onco Targets Ther       Date:  2020-03-18       Impact factor: 4.147

6.  MRIP Regulates the Myosin IIA Activity and DDR1 Function to Enable Collagen Tractional Remodeling.

Authors:  Nuno M Coelho; Andrew Wang; Petar Petrovic; Yongqiang Wang; Wilson Lee; Christopher A McCulloch
Journal:  Cells       Date:  2020-07-11       Impact factor: 6.600

Review 7.  Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies.

Authors:  Lornella Seeneevassen; Emilie Bessède; Francis Mégraud; Philippe Lehours; Pierre Dubus; Christine Varon
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

8.  Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB/c nude mice model.

Authors:  Seon-Jin Yoon; Jungmin Park; Youngmin Shin; Yuna Choi; Sahng Wook Park; Seok-Gu Kang; Hye Young Son; Yong-Min Huh
Journal:  BMC Cancer       Date:  2020-04-15       Impact factor: 4.430

9.  Silencing of sinusoidal DDR1 reduces murine liver metastasis by colon carcinoma.

Authors:  Irene Romayor; Iker Badiola; Aitor Benedicto; Joana Márquez; Alba Herrero; Beatriz Arteta; Elvira Olaso
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

10.  Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib.

Authors:  Raquel Carvalho Montenegro; Alison Howarth; Alessandro Ceroni; Vita Fedele; Batoul Farran; Felipe Pantoja Mesquita; Martin Frejno; Benedict-Tilman Berger; Stephanie Heinzlmeir; Heba Z Sailem; Roberta Tesch; Daniel Ebner; Stefan Knapp; Rommel Burbano; Bernhard Kuster; Susanne Müller
Journal:  Oncotarget       Date:  2020-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.